Article Text

Download PDFPDF
P346 Comparing of monitoring successfull therapy for two drugs in obstructive pulmonary disease at children aged one to four years
  1. Bajraktarevic Adnan1,
  2. Krdzalic Zecevic Belma1,
  3. Husic Fuad1,
  4. Jatic Zaim1,
  5. Firdus Tiric Djana1,
  6. Pahor Kurilic Andrea1,
  7. Djukic Branka1,
  8. Sporisevic Lutvo2,
  9. Selimovic Amina3,
  10. Suljevic Ismet4,
  11. Niksic Haris5,
  12. Krupic Ferid6
  1. 1Paediatrics Department, Public Health Institution of Sarajevo Canton
  2. 2Paediatrics Department, First Medical Aid
  3. 3Pulmonology Department, Paediatrics Clinic
  4. 4Biochemistry Department, Clinical Medical Centre
  5. 5Department for Clinical Pharmacology, Pharmaceutical Faculty Sarajevo, Sarajevo, Bosnia-Herzegovina
  6. 6Clinical Centre Gothenburg Sweden


Introduction Monitoring the success of treatment with inhaled corticosteroid fluticasone propionate type comparing with inbibitor of leukotriene, montelukast in preschool children is an everyday topic. Control of chronic obstructive pulmonary disease is one of the most important issues today in paediatrics, especially in paediatric pulmonology.

Objective Improving control of chronic obstructive pulmonary disease in children at an early stage of the disease from twelve months by the age of four.

Methods The study included all children between the ages of twelve months to four years of age with obstructive bronchitis in the dispensary Centre Sarajevo. Total 360 children divided into three age groups and the same number use two different drug fluticasone propionate inhaled or montelukast in the form of granules in sixty sick children in each age subgroup. Authors were excluded children with antibiotic therapy in this reasearch.

Results The drug of fluticasone propionate proved slightly more effective in controlling these diseases in the percentage of 96% relative to other drug montelukast with 93% of the total of all age groups. No significant differences in age groups and in relation to sex of children.

Conclusion Both drug and fluticasone propionate and montelukast have shown excellent disease control but can not be given to any advantage in monitoring chronic obstructive pulmonary disease in preschool children.

  • Preschool
  • Children
  • Montelukast
  • Fluticasone propionate
  • Asthma

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.